Can Pacific Biosciences of California Inc (PACB) Stock Rise to the Top of Healthcare Sector Friday?

Pacific Biosciences of California Inc (PACB) is near the top in its sector according to InvestorsObserver. PACB gets an overall rating of 79. That means it scores higher than 79% of stocks. Pacific Biosciences of California Inc gets a 77 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

PACB has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on PACB!

See Full PACB Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 79 would rank higher than 79 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Pacific Biosciences of California Inc Stock Today?

Pacific Biosciences of California Inc (PACB) stock is up 2.22% while the S&P 500 has fallen -0.11% as of 12:01 PM on Friday, Mar 24. PACB has risen $0.20 from the previous closing price of $9.24 on volume of 1,004,652 shares. Over the past year the S&P 500 is down -12.74% while PACB has fallen -2.28%. PACB lost -$1.40 per share the over the last 12 months. Click Here to get the full Stock Report for Pacific Biosciences of California Inc stock.